Kärcher and R‑Zero Partner to Deliver UV‑C Disinfection Solution across North America

Business Wire, Inc.
April 16, 2021

Kärcher North Amer­i­ca, a sub­sidiary of glob­al clean­ing tech­nol­o­gy leader Alfred Kärcher, GmbH & Co, today announced a part­ner­ship with biosafe­ty com­pa­ny, R‑Zero, to dis­trib­ute R‑Zero’s hos­pi­tal-grade UV‑C dis­in­fec­tion sys­tem, Arc. Kärcher will lever­age its robust North Amer­i­can pres­ence to deliv­er Arc’s sus­tain­able dis­in­fec­tion tech­nol­o­gy to more orga­ni­za­tions as the nation reopens.

Kärcher makes pow­er­ful and effi­cient clean­ing solu­tions for home and pro­fes­sion­al use. Found­ed in 1935, Kärcher has a sim­ple inno­va­tion phi­los­o­phy: inno­va­tion is what ben­e­fits the cus­tomers. Today, approx­i­mate­ly 90 per­cent of all Kärcher’s prod­ucts are five years old or younger, and R‑Zero’s Arc is the lat­est exam­ple of Kärcher’s com­mit­ment to help­ing orga­ni­za­tions nav­i­gate the COVID-19 pan­dem­ic with break­through technology.

Kärcher con­tin­ues to look for oppor­tu­ni­ties to offer high qual­i­ty, high per­form­ing dis­in­fec­tion devices,” said Rex Shull, ‎Vice Pres­i­dent of Prod­uct Man­age­ment and Engi­neer­ing at Kärcher North Amer­i­ca. “When choos­ing a UV‑C part­ner, we want­ed best in-class tech­nol­o­gy, ease of use and afford­abil­i­ty — all fea­tures we found in Arc. Arc helps us to offer solu­tions that will not only help busi­ness­es open, but allow them to stay open in these uncer­tain times.”

R‑Zero was found­ed in the ear­ly days of the pan­dem­ic with the goal of mak­ing hos­pi­tal-grade dis­in­fec­tion tech­nolo­gies more acces­si­ble, start­ing with Arc. Arc is a touch­less, hos­pi­tal-grade ger­mi­ci­dal UV‑C device, proven to destroy over 99.99% of sur­face and air­borne pathogens in a 1,000 sq ft space, in just 7 min­utes. BLE and LTE‑M con­nec­tiv­i­ty shares usage data in real time, pro­vid­ing orga­ni­za­tions with an auditable trail of all dis­in­fec­tion activities.

In less than a year, R‑Zero’s Arc has emerged as a pre­ferred mar­ket solu­tion for a vari­ety of busi­ness­es and sec­tors thanks to its acces­si­ble pric­ing, con­sumer-friend­ly inter­face, and sci­en­tif­ic validation.

To read more, please vis­it: Busi​ness​wire​.com